Publications: Kibble, Emily

2022

Iwasaki, J., Lorimer, D.D., Vivoli-Vega, M., Kibble, E.A., Peacock, C.S., Abendroth, J., Mayclin, S.J., Dranow, D.M., Pierce, P.G., Fox, D., Lewis, M., Bzdyl, N.M., Kristensen, S.S., Inglis, T.J.J., Kahler, C.M., Bond, C.S., Hasenkopf, A., Seufert, F., Schmitz, J., Marshall, L.E., Scott, A.E., Norville, I.H., Myler, P.J., Holzgrabe, U., Harmer, N.J. and Sarkar-Tyson, M. (2022) Broad-spectrum in vitro activity of macrophage infectivity potentiator inhibitors against Gram-negative bacteria and Leishmania major. Journal of Antimicrobial Chemotherapy, 77 (6). pp. 1625-1634.

2021

Lim, K.Y.L., Mullally, C.A., Haese, E.C., Kibble, E.A., McCluskey, N.R., Mikucki, E.C., Thai, V.C., Stubbs, K.A., Sarkar-Tyson, M. and Kahler, C.M. (2021) Anti-virulence therapeutic approaches for Neisseria gonorrhoeae. Antibiotics, 10 (2). Article 103.

Kibble, Emily A. (2021) The role of FK506 Binding Proteins in the virulence of Neisseria meningitidis. PhD thesis, Murdoch University.

2020

Scheuplein, N.J., Bzdyl, N.M., Kibble, E.A., Lohr, T., Holzgrabe, U. and Sarkar-Tyson, M. (2020) Targeting protein folding: A novel approach for the treatment of pathogenic bacteria. Journal of Medicinal Chemistry, 63 (22). pp. 13355-13388.